BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 31142515)

  • 1. The Highly Recurrent PP2A Aα-Subunit Mutation P179R Alters Protein Structure and Impairs PP2A Enzyme Function to Promote Endometrial Tumorigenesis.
    Taylor SE; O'Connor CM; Wang Z; Shen G; Song H; Leonard D; Sangodkar J; LaVasseur C; Avril S; Waggoner S; Zanotti K; Armstrong AJ; Nagel C; Resnick K; Singh S; Jackson MW; Xu W; Haider S; DiFeo A; Narla G
    Cancer Res; 2019 Aug; 79(16):4242-4257. PubMed ID: 31142515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Precision Therapy for Aggressive Endometrial Cancer by Reactivation of Protein Phosphatase 2A.
    Haines K; Huang GS
    Cancer Res; 2019 Aug; 79(16):4009-4010. PubMed ID: 31416848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of PP2A by a recurrent mutation drives resistance to MEK inhibitors.
    O'Connor CM; Leonard D; Wiredja D; Avelar RA; Wang Z; Schlatzer D; Bryson B; Tokala E; Taylor SE; Upadhyay A; Sangodkar J; Gingras AC; Westermarck J; Xu W; DiFeo A; Brautigan DL; Haider S; Jackson M; Narla G
    Oncogene; 2020 Jan; 39(3):703-717. PubMed ID: 31541192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent PPP2R1A Mutations in Uterine Cancer Act through a Dominant-Negative Mechanism to Promote Malignant Cell Growth.
    Haesen D; Abbasi Asbagh L; Derua R; Hubert A; Schrauwen S; Hoorne Y; Amant F; Waelkens E; Sablina A; Janssens V
    Cancer Res; 2016 Oct; 76(19):5719-5731. PubMed ID: 27485451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subtype-specific mutation of PPP2R1A in endometrial and ovarian carcinomas.
    McConechy MK; Anglesio MS; Kalloger SE; Yang W; Senz J; Chow C; Heravi-Moussavi A; Morin GB; Mes-Masson AM; ; Carey MS; McAlpine JN; Kwon JS; Prentice LM; Boyd N; Shah SP; Gilks CB; Huntsman DG
    J Pathol; 2011 Apr; 223(5):567-73. PubMed ID: 21381030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting Ribonucleotide Reductase Induces Synthetic Lethality in PP2A-Deficient Uterine Serous Carcinoma.
    O'Connor CM; Taylor SE; Miller KM; Hurst L; Haanen TJ; Suhan TK; Zawacki KP; Noto FK; Trako J; Mohan A; Sangodkar J; Zamarin D; DiFeo A; Narla G
    Cancer Res; 2022 Feb; 82(4):721-733. PubMed ID: 34921012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein phosphatase 2A Aα regulates Aβ protein expression and stability.
    O'Connor CM; Hoffa MT; Taylor SE; Avelar RA; Narla G
    J Biol Chem; 2019 Apr; 294(15):5923-5934. PubMed ID: 30796164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Cancer-Associated Missense Mutation in PP2A-Aα Increases Centrosome Clustering during Mitosis.
    Antao NV; Marcet-Ortega M; Cifani P; Kentsis A; Foley EA
    iScience; 2019 Sep; 19():74-82. PubMed ID: 31357169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation of PPP2R1A: a new clue in unveiling the pathogenesis of uterine serous carcinoma.
    Shih IeM; Wang TL
    J Pathol; 2011 May; 224(1):1-4. PubMed ID: 21432855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient derived mutation W257G of PPP2R1A enhances cancer cell migration through SRC-JNK-c-Jun pathway.
    Jeong AL; Han S; Lee S; Su Park J; Lu Y; Yu S; Li J; Chun KH; Mills GB; Yang Y
    Sci Rep; 2016 Jun; 6():27391. PubMed ID: 27272709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human cancer-associated mutations in the Aα subunit of protein phosphatase 2A increase lung cancer incidence in Aα knock-in and knockout mice.
    Ruediger R; Ruiz J; Walter G
    Mol Cell Biol; 2011 Sep; 31(18):3832-44. PubMed ID: 21791616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Domains necessary for Galpha12 binding and stimulation of protein phosphatase-2A (PP2A): Is Galpha12 a novel regulatory subunit of PP2A?
    Zhu D; Tate RI; Ruediger R; Meigs TE; Denker BM
    Mol Pharmacol; 2007 May; 71(5):1268-76. PubMed ID: 17303700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PPP2R1A mutation is a rare event in ovarian carcinoma across histological subtypes.
    Rahman M; Nakayama K; Rahman MT; Nakayama N; Katagiri H; Katagiri A; Ishibashi T; Ishikawa M; Iida K; Otsuki Y; Nakayama S; Miyazaki K
    Anticancer Res; 2013 Jan; 33(1):113-8. PubMed ID: 23267135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PP2A: A Promising Biomarker and Therapeutic Target in Endometrial Cancer.
    Remmerie M; Janssens V
    Front Oncol; 2019; 9():462. PubMed ID: 31214504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. De Novo Mutations Affecting the Catalytic Cα Subunit of PP2A, PPP2CA, Cause Syndromic Intellectual Disability Resembling Other PP2A-Related Neurodevelopmental Disorders.
    Reynhout S; Jansen S; Haesen D; van Belle S; de Munnik SA; Bongers EMHF; Schieving JH; Marcelis C; Amiel J; Rio M; Mclaughlin H; Ladda R; Sell S; Kriek M; Peeters-Scholte CMPCD; Terhal PA; van Gassen KL; Verbeek N; Henry S; Scott Schwoerer J; Malik S; Revencu N; Ferreira CR; Macnamara E; Braakman HMH; Brimble E; Ruzhnikov MRZ; Wagner M; Harrer P; Wieczorek D; Kuechler A; Tziperman B; Barel O; de Vries BBA; Gordon CT; Janssens V; Vissers LELM
    Am J Hum Genet; 2019 Jan; 104(1):139-156. PubMed ID: 30595372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PPP2R1A mutations are common in the serous type of endometrial cancer.
    Nagendra DC; Burke J; Maxwell GL; Risinger JI
    Mol Carcinog; 2012 Oct; 51(10):826-31. PubMed ID: 21882256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mouse model for probing tumor suppressor activity of protein phosphatase 2A in diverse signaling pathways.
    Walter G; Ruediger R
    Cell Cycle; 2012 Feb; 11(3):451-9. PubMed ID: 22262169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional importance of PP2A regulatory subunit loss in breast cancer.
    Watt LF; Panicker N; Mannan A; Copeland B; Kahl RGS; Dun MD; Young B; Roselli S; Verrills NM
    Breast Cancer Res Treat; 2017 Nov; 166(1):117-131. PubMed ID: 28744751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B56δ-related protein phosphatase 2A dysfunction identified in patients with intellectual disability.
    Houge G; Haesen D; Vissers LE; Mehta S; Parker MJ; Wright M; Vogt J; McKee S; Tolmie JL; Cordeiro N; Kleefstra T; Willemsen MH; Reijnders MR; Berland S; Hayman E; Lahat E; Brilstra EH; van Gassen KL; Zonneveld-Huijssoon E; de Bie CI; Hoischen A; Eichler EE; Holdhus R; Steen VM; Døskeland SO; Hurles ME; FitzPatrick DR; Janssens V
    J Clin Invest; 2015 Aug; 125(8):3051-62. PubMed ID: 26168268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and functional analyses of polymorphism haplotypes of protein phosphatase 2A-Aα gene promoter.
    Lin YC; Chen HF; Lin LN; Luo J; Li W; Zhang SJ; Li XJ; Hu YM; Chen YX; Chen W; Lin ZN
    Mutat Res; 2011 Nov; 716(1-2):66-75. PubMed ID: 21889517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.